蓝丰生化：股票交易异常波动

Core Viewpoint - The company, Bluefeng Biochemical, announced that its stock experienced an abnormal trading fluctuation with a cumulative closing price deviation exceeding 20% over two consecutive days, indicating potential market volatility [1] Group 1: Company Performance - The company confirmed that its operational status remains normal and that there have been no significant changes in the internal or external environment [1] - There are no undisclosed significant information that the company is required to disclose [1] Group 2: Stock Activity - The controlling shareholder and actual controller did not engage in any buying or selling of the company's stock during the period of abnormal trading [1] - The company has approved a restricted stock incentive plan related to its stock [1] Group 3: Investor Advisory - The company advises investors to pay attention to official disclosure channels and to be cautious of investment risks [1]